Risk of Anemia in Chronic Disease in Patients With or Without Cancer
Release
Date: August
22, 2006
Expiration Date: August 21, 2007
Target
Audience
Physicians involved in the care of patients with cancer. Statement
of Need
Physicians who care for patients with cancer need the most current
information on cancer care. This activity will help the practitioner assess risk
and diagnose anemia in chronic disease in patients with or without cancer in
order to appropriately treat and improve the patients quality of life.
Educational
Objectives
Upon completion of this activity, participants should be able
to improve their patient care by being able to: - Evaluate the risk of anemia in chronic disease
-
Recognize the development of anemia and apply appropriate treatment
-
Assess the patient and perform appropriate diagnostic tests
Faculty
Accreditation
Physicians
Creative Educational Concepts, Inc. is accredited by the Accreditation Council
of Continuing Medical Education (ACCME) to provide continuing medical education
for physicians.
Creative Educational Concepts, Inc. designates this educational
activity for a maximum of .5 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their
participation
in
the activity.
Instructions
To receive credit for this activity, you must:
- Review the full
content of the activity and reflect on its teaching.
- Successfully
complete the post-test with a minimum grade of 70% or higher.
- You
will have two (2) opportunities to successfully complete the activity.
Your
statement of credit will be issued immediately upon successful completion of the
post-test and submission of the evaluation. Fee
There is no fee for this activity. Disclosure
Declaration
It is the policy of Creative Educational Concepts, Inc. for
individuals who are in a position to control the content of an educational activity
to disclose to the learners all relevant financial relationships that they have
with any commercial interest(s) that provide products or services that may be
relevant to the content of this continuing medical education activity.Creative
Educational Concepts, Inc. has no relevant financial relationship with any commercial
interests related directly or indirectly to the content of this educational activity.
Howard
Ozer, MD, PhD has disclosed that he is a consultant with Amgen Inc.,
Biogen Idec, and sanofi-aventis. He has received grant/reserach support
from Amgen Inc., Abraxis BioScience, Inc., Novartis, Pfizer, Inc., and
sanofi-aventis. He is also on the speakers' bureau for Amgen Inc., Bayer,
and sanofi-aventis.
It is the policy of the accreditors to ensure independence, balance, objectivity,
scientific rigor, and integrity in all of their continuing medical education
activities.
Unlabeled
Use Disclosure
The author and sponsor of this continuing medical education
activity have made all reasonable efforts to ensure that information contained
herein is accurate in accordance with the latest available scientific knowledge
at the time of accreditation of this continuing education activity. Information
regarding drugs (e.g. their administration, dosages, contraindications, adverse
reactions, interactions, special warnings, precautions) and drug delivery systems
is subject to change; however, and the reader is advised to check the manufacturer's
package insert for information concerning recommended dosage and potential problems
or cautions prior to dispensing or administering the drug or using the drug delivery
system.
The faculty has indicated that there will be discussion of unlabeled/unapproved
use of products during the presentation. Commercial
Support
 | This
activity is supported by an educational grant from Amgen Inc. |
Software Requirements
Continue |
